Chambers Review
Provided by Chambers
Capital Markets: Hong Kong and Overseas Issuances - China
What the Team is Known For
JunHe LLP is a prominent practice with a sizeable team of securities and corporate law practitioners, a few of whom are former members of the CSRC Listing Review & Examination Committee. It is best known for its expertise in Hong Kong and US-related offerings while attracting admirable levels of A-share listing work, with a particularly healthy roster of domestic clients in the healthcare sector and construction industry. The team remains a counsel of choice for technology sector IPOs. The firm is sought out by underwriters and issuers in respect of listings, bonds and preferred shares matters. Clients also benefit from its offices in New York and Silicon Valley.
Strengths
The team members possess years of practical experience in the capital markets and have participated in numerous large-scale equity and debt projects, including IPOs, refinancings, and bond issuances.
JunHe provides great service and professionals. Its team has been in this field for many years, and is very familiar with capital investment funds and practices and risks.
Work Highlights
JunHe LLP assisted Shanghai Xiaofang Pharmaceutical with its A-share listing on the Main Board of the Shanghai Stock Exchange.
JunHe advised XtalPi on its successful listing on the Main Board of the Hong Kong Stock Exchange.
Notable practitioners
Shao Chunyang remains active and diligent.
Shi Tiejun has a longstanding presence and a well-deserved reputation when it comes to bond and equity issuances, specialising in A-share listings including those on the STAR Market. He ably advises corporates on spin-off listings.
Yu Yongqiang is well regarded for his ability to handle complex issuance mandates on domestic and overseas markets. His deft handling of debt capital markets work is highly sought after by clients, especially when it comes to offshore bond issuances.
Yu is strong in debt issuances. DCM is his area.
Wang is a great lawyer to work with in a long term. With in-depth understanding of the management’s perspective, he is someone we will always go to before we make crucial commercial decisions.
业务优势
君合律师事务所的业务表现突出，拥有庞大的证券和公司法团队, 其中多位曾担任中国证监会发行审核委员会委员。其在各类香港和美国相关发行的专业能力最为著名，同时吸引到了相当体量的A股上市业务，尤其在医疗健康行业和建设工程产业拥有发展势头良好的客户群。该团队持续成为服务科技领域IPO的律所之选。该律所在上市、 债券和优先股领域受到承销商和发行人的追捧。客户还受益于他们设在纽约和硅谷的办公室。
市场评价
君合提供优质的服务和专业的团队。其团队在该领域拥有多年经验，非常熟悉资本投资基金、运作方式和风险。
团队成员在资本市场领域拥有多年的实战经验，参与过众多大型股权、债权项目，包括 IPO、再融资、债券发行等。
业务亮点
君合律师事务所协助上海小方药业在上海证券交易所主板上市。
领先律师
邵春阳律师依然积极勤奋。
余永强律师因其处理国内外市场复杂的发行工作的能力而备受好评。他娴熟的债务资本市场业务处理能力深受客户青睐，尤其是在离岸债券发行方面。
余永强律师擅长处理债券发行，债务资本市场（DCM）是他的专长领域。
王律师是一位非常值得长期合作的优秀律师。他对管理层的视角有着深刻的理解，因此在做出任何关键的商业决策之前，我们都会向他咨询。